Background and Aim The full disclosure of all locations at which research is conducted is an important requirement of clinical trial registration. Yet, little is known about how well researchers and sponsors disclose this information in their registrations. The aim of this study is to examine the adequacy of study location disclosure on http://ClinicalTrials.gov/ for recent USA-sponsored research in the Russian Federation.
Methods and Results Information from advertisements for clinical research participation opportunities in Russia was compared with that in the corresponding trial registration in http://ClinicalTrials.gov/. Of 218 USA-sponsored trials advertised to Russian patients and physicians, nearly one-third did not disclose Russia as a study location in the registration. Longer trials were more likely to specify Russia as a study location.
Conclusion This study found that recent USA-sponsored clinical trials advertised to patients and physicians in the Russian Federation often do not specify Russia as a study location in their registrations on http://ClinicalTrials.gov/. The failure to fully disclose the locations at which research takes place undermines patients' ability to access information about potentially beneficial research opportunities, limits access to information, which may be important for identifying or avoiding ethically questionable practices, and may frustrate the ability to interpret the results of research.
- Trial registration
- study locations
- research on special populations
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Competing interests None.
Provenance and peer review Not commissioned; externally peer reviewed.
Read the full text or download the PDF:
Other content recommended for you
- Trends in global clinical trial registration: an analysis of numbers of registered clinical trials in different parts of the world from 2004 to 2013
- Prospective registration and reporting of trial number in randomised clinical trials: global cross sectional study of the adoption of ICMJE and Declaration of Helsinki recommendations
- How to avoid common problems when using ClinicalTrials.gov in research: 10 issues to consider
- Clinical trial registration, reporting, publication and FDAAA compliance: a cross-sectional analysis and ranking of new drugs approved by the FDA in 2012
- Quality assessment of clinical trial registration with traditional Chinese medicine in WHO registries
- Impact of sending email reminders of the legal requirement for posting results on ClinicalTrials.gov: cohort embedded pragmatic randomized controlled trial
- Publication of NIH funded trials registered in ClinicalTrials.gov: cross sectional analysis
- Overview of phase IV clinical trials for postmarket drug safety surveillance: a status report from the ClinicalTrials.gov registry
- Pharmaceutical companies’ policies on access to trial data, results, and methods: audit study
- Clinical trial transparency: a reassessment of industry compliance with clinical trial registration and reporting requirements in the United States